Disarm Therapeutics

Disarm Therapeutics

Disarm Therapeutics

Disarm Therapeutics is creating breakthrough therapeutics for patients with neurological diseases by preventing axonal degeneration.
Founded
2016
Raised
$30M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$30,000,000
Venture capital (Series A) - 2017
Atlas Venture AbbVie Biotech Ventures Lightstone Ventures
Team Size
10+
Employees
the home of AI info

Disarm Therapeutics Reports Preclinical Data Demonstrating Small Molecule SARM1 Inhibitors ...